Andrew Huberman· PhD
So, to me, you're... I'm not reviewing your grant. But from a rational perspective, it seems that drugs that increase certain neuromodulators, like serotonin or dopamine, in a controlled way, and then coupling that with learning of some sort, sensory input of some sort, it makes sense that would lead to, could, I should say, lead to reordering of circuitry that would allow for better thinking, better mood, many of the same things that you've observed in the clinical trials for depression.